Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > CA Providers > Hematologists

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD

(Dr. Ajai Chari, MD)

(No ratings)

Specializes in: Hematology (Blood Disorders), General Practice and Oncology (Cancer Care)

University of California, Los Angeles (UCLA), David Geffen School of Medicine

Professional interests include: myeloma

400 Parnassus Avenue Fourth Floor
San Francisco, CA 94143

(415) 353-2051

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD is a hematologist in San Francisco, CA specializing in hematology (blood disorders), general practice and oncology (cancer care). He graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine. Dr. Ajai Chari, Hematology Oncology | Myeloma, MD is affiliated with UCSF Health, UCSF Medical Group, UCSF, Hill Physicians and Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program.

Office Locations

400 Parnassus Avenue Fourth Floor
San Francisco, CA 94143

open_in_new

In The News (see more mentions in the news)

“In a 288-patient, phase I/II study that assessed the agent's efficacy with two different dosing regimens -- 0.4 mg/kg weekly and 0.8 mg/kg every other week -- response rates were 74.1% and 73.1%,...”—"Talquetamab Offers New Hope in Relapsed/Refractory Multiple Myeloma", MedPage Today, December 2022

“"It requires quite a bit of work," usually at least 24 hours over several weeks, said Dr. Ajai Chari at Mount Sinai's Tisch Cancer Institute in New York where dozens of patients have gotten...”—"US aims to help more cancer patients try experimental drugs", New York Post, June 2019

“"It requires quite a bit of work," usually at least 24 hours over several weeks, said Dr. Ajai Chari at Mount Sinai s Tisch Cancer Institute in New York where dozens of patients have gotten...”—"US aims to help more cancer patients try experimental drugs", South Florida Sun-Sentinel, June 2019

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2013 were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

aspiration	32
bone marrow tests	65
diagnostic procedures	65
doctor visit	387
hospital care	144
inpatient care	144

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	84
Female	67

**Ethnicity**
Non-Hispanic White	86
Black	30
Hispanic	24
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	72
From 75 to 84	37
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2013

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2013 were hypertension, chronic kidney disease, diabetes and heart failure.

Hypertension	70
High Cholesterol	40
Stroke	0
Ischemic Heart Disease	40
Depression	22
Chronic Kidney Disease	48
Asthma	11
Osteoperosis	10
Atrial Fibrilation	10
Heart Failure	40
Chronic Obstructive Pulmonary Disease	9
Diabetes	43
Dementia	7
Cancer	13

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2014 were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

aspiration	13
bone marrow tests	26
diagnostic procedures	26
doctor visit	330
hospital care	153
inpatient care	153

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	82
Female	68

**Ethnicity**
Non-Hispanic White	88
Black	28
Hispanic	22
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	74
From 75 to 84	35
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2014

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2014 were hypertension, high cholesterol, chronic kidney disease and diabetes.

Hypertension	69
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	43
Depression	23
Chronic Kidney Disease	51
Asthma	12
Osteoperosis	7
Atrial Fibrilation	8
Heart Failure	39
Chronic Obstructive Pulmonary Disease	13
Diabetes	43
Dementia	8
Cancer	15

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2015 were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

aspiration	28
bone marrow tests	56
diagnostic procedures	56
doctor visit	345
hospital care	180
inpatient care	180

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	176
Female	150

**Ethnicity**
Non-Hispanic White	208
Black	56
Hispanic	36
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	182
From 75 to 84	80
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2015

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2015 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	72
High Cholesterol	40
Stroke	0
Ischemic Heart Disease	40
Depression	25
Chronic Kidney Disease	50
Asthma	14
Osteoperosis	14
Atrial Fibrilation	15
Heart Failure	36
Chronic Obstructive Pulmonary Disease	13
Diabetes	36
Dementia	10
Cancer	17

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2016 were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

aspiration	47
bone marrow tests	94
diagnostic procedures	94
doctor visit	375
hospital care	201
inpatient care	201

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	108
Female	84

**Ethnicity**
Non-Hispanic White	123
Black	40
Hispanic	16
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	101
From 75 to 84	48
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2016

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2016 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	71
High Cholesterol	51
Stroke	0
Ischemic Heart Disease	41
Depression	30
Chronic Kidney Disease	53
Asthma	14
Osteoperosis	10
Atrial Fibrilation	8
Heart Failure	36
Chronic Obstructive Pulmonary Disease	10
Diabetes	34
Dementia	13
Cancer	16

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2017 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	425
hospital care	184
inpatient care	184

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	96
Female	82

**Ethnicity**
Non-Hispanic White	111
Black	36
Hispanic	13
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	100
From 75 to 84	40
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2017

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2017 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	75
High Cholesterol	44
Stroke	0
Ischemic Heart Disease	40
Depression	24
Chronic Kidney Disease	57
Asthma	10
Osteoperosis	16
Atrial Fibrilation	10
Heart Failure	37
Chronic Obstructive Pulmonary Disease	12
Diabetes	35
Dementia	13
Cancer	15

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2018 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	491
hospital care	143
inpatient care	143

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	128
Female	88

**Ethnicity**
Non-Hispanic White	147
Black	30
Hispanic	18
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	121
From 75 to 84	47
85 and over	15
Less than 65	33

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2018

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2018 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	67
High Cholesterol	45
Stroke	0
Ischemic Heart Disease	38
Depression	23
Chronic Kidney Disease	50
Asthma	6
Osteoperosis	13
Atrial Fibrilation	10
Heart Failure	33
Chronic Obstructive Pulmonary Disease	11
Diabetes	31
Dementia	12
Cancer	14

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2019 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	509
hospital care	129
inpatient care	129

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	123
Female	92

**Ethnicity**
Non-Hispanic White	138
Black	39
Hispanic	19
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	124
From 75 to 84	51
85 and over	11
Less than 65	29

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2019

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2019 were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	75
High Cholesterol	53
Stroke	5
Ischemic Heart Disease	41
Depression	20
Chronic Kidney Disease	58
Asthma	7
Osteoperosis	11
Atrial Fibrilation	9
Heart Failure	33
Chronic Obstructive Pulmonary Disease	11
Diabetes	37
Dementia	13
Cancer	14

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2020 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	351
hospital care	116
inpatient care	116

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	115
Female	83

**Ethnicity**
Non-Hispanic White	135
Black	30
Hispanic	15
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	103
From 75 to 84	57
85 and over	16
Less than 65	22

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2020

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2020 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	64
High Cholesterol	58
Stroke	6
Ischemic Heart Disease	41
Depression	18
Chronic Kidney Disease	49
Asthma	6
Osteoperosis	13
Atrial Fibrilation	13
Heart Failure	26
Chronic Obstructive Pulmonary Disease	11
Diabetes	31
Dementia	14
Cancer	15

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2021 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	502
hospital care	136
inpatient care	136

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	117
Female	86

**Ethnicity**
Non-Hispanic White	139
Black	33
Hispanic	18
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	103
From 75 to 84	66
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2021

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2021 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	70
High Cholesterol	56
Stroke	0
Ischemic Heart Disease	38
Depression	25
Chronic Kidney Disease	46
Asthma	10
Osteoperosis	17
Atrial Fibrilation	14
Heart Failure	27
Chronic Obstructive Pulmonary Disease	6
Diabetes	29
Dementia	14
Cancer	16

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA during 2022 were hospital care and inpatient care.

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	511
hospital care	178
inpatient care	178

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	125
Female	97

**Ethnicity**
Non-Hispanic White	156
Black	35
Hispanic	15
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	97
From 75 to 84	80
85 and over	16
Less than 65	29

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2022

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2022 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	75
High Cholesterol	65
Stroke	10
Ischemic Heart Disease	32
Depression	18
Chronic Kidney Disease	35
Asthma	10
Osteoperosis	21
Atrial Fibrilation	23
Heart Failure	26
Chronic Obstructive Pulmonary Disease	10
Diabetes	29
Dementia	9
Cancer	18

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

doctor visit	143

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	80
Female	72

**Ethnicity**
Non-Hispanic White	117
Black	12
Hispanic	0
Asian	11
Other	0
Native American	0

**Age**
From 65 to 74	70
From 75 to 84	62
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2023

The most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated during 2023 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	75
High Cholesterol	68
Stroke	0
Ischemic Heart Disease	29
Depression	18
Chronic Kidney Disease	43
Asthma	11
Osteoperosis	24
Atrial Fibrilation	24
Heart Failure	26
Chronic Obstructive Pulmonary Disease	13
Diabetes	23
Dementia	0
Cancer	16

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Volume of procedures performed by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD for Medicare patients.

The highest averages for the top procedures that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated as a hematologist in San Francisco, CA were hospital care, inpatient care, diagnostic procedures and bone marrow tests.

aspiration	30
bone marrow tests	60
diagnostic procedures	60
doctor visit	397
hospital care	156
inpatient care	156

Average Medicare Patient Data From 2013 - 2023

Information about Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD.

**Gender**
Male	112
Female	88

**Ethnicity**
Black / African American	33
Asian / Pacific Islander	1
Non-Hispanic White	131
Native American / Alaskan Native	0
Hispanic	17
Other	0

**Age**
75 to 84	54
85 and over	5
Less than 65	10
65 to 74	104

Average of Total of Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD From 2013 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Ajai Chari, Hematology Oncology | Myeloma, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	71
High Cholesterol	52
Stroke	1
Ischemic Heart Disease	38
Depression	22
Chronic Kidney Disease	49
Asthma	10
Osteoporosis	14
Heart Failure	32
Chronic Obstructive Pulmonary Disease	10
Diabetes	33
Atrial Fibrillation	13
Cancer	15
Dementia	10

Education & Training

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD graduated from University of California, Los Angeles (UCLA), David Geffen School of Medicine. He completed residency at Columbia University Affiliated Hospitals. He is certified by the American Board of Internal Medicine, Hematology and has a state license in New York.

Medical School: University of California, Los Angeles (UCLA), David Geffen School of Medicine

Residency: Columbia University Affiliated Hospitals (2002)

Board Certification: American Board of Internal Medicine, Hematology (2006)

Licensed In: New York

Affiliations & Hospitals

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD is associated with these hospitals and organizations:

UCSF Health

UCSF Medical Group

UCSF

Hill Physicians

Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD appears to accept the following insurance providers: Cigna, Aetna, Blue Shield of California, Anthem, UnitedHealthcare, Health Net, Chinese Community Health Plan, Central Health Plan and Canopy Health.

Insurance Accepted by Provider includes:

According to our sources, Dr. Ajai Chari, Hematology Oncology | Myeloma, MD accepts the following insurance providers:

Cigna

Aetna

Blue Shield of California

Anthem

UnitedHealthcare

Health Net

Chinese Community Health Plan

Central Health Plan

Canopy Health

Ratings & Reviews

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD does not have any reviews yet, be the first to leave a review of Dr. Ajai Chari, Hematology Oncology | Myeloma, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Celgene Corporation	$82,814 Revlimid $41,979	Pomalyst $15,248	JCAR017 $4,000	ABECMA $125	$21,462
Takeda Pharmaceuticals U.S.A., Inc.	$74,509 NINLARO $11,845	$62,664
Amgen Inc.	$73,619 Kyprolis $59,086	Nplate $1,375	$13,158
GENZYME CORPORATION	$69,972 SARCLISA $46,030	CD38 $12,155	MOZOBIL $8,542	$3,244
Millennium Pharmaceuticals, Inc.	$54,216 NINLARO $6,434	VELCADE $6,426	ixazomibMLN9708 $5,999	ADCETRIS $68	$35,288
Other	$244,515 FARYDAK $41,844	DARZALEX $38,994	XPOVIO $15,250	IVIG $13,231	EMPLICITI $9,908	Other $125,288

**Types of Payments**
Consulting Fee	$363,437
Travel and Lodging	$106,345
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$60,073
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program	$28,369
Honoraria	$23,479
Other	$17,940

Research Payments

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD has received 802 research payments totaling $32,373,360.

Biography

Dr. Ajai Chari specializes in general practice, oncology (cancer care), and hematology (blood disorders). He attended the University of California, Los Angeles (UCLA), David Geffen School of Medicine and then went on to complete his residency at a hospital affiliated with Columbia University. He is especially interested in myeloma. Dr. Chari can take several insurance carriers, including Blue Shield, Health Net, and Anthem. He is professionally affiliated with UCSF Medical Group and Hill Physicians.

Select Year:

Dr. Ajai Chari, Hematology Oncology | Myeloma, MD

Office Locations

In The News (see more mentions in the news)

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

2021 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2021

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

2022 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2022

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

2023 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD in 2023

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2013 - 2023

Average Medicare Patient Data From 2013 - 2023

Average of Total of Conditions of Medicare patients treated by Dr. Ajai Chari, Hematology Oncology | Myeloma, MD From 2013 - 2023

Education & Training

Affiliations & Hospitals

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

Hematologists in Nearby Locations

Other Providers in San Francisco, CA